Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset

Blood

Volumn 117, Issue 20, 2011, Pages 5425-5437

  Charles, Edgar D ^a,b   Brunetti, Claudia ^a,c   Marukian, Svetlana ^a   Ritola, Kimberly D ^a   Talal, Andrew H ^b   Marks, Kristen ^b   Jacobson, Ira M ^b   Rice, Charles M ^a   Dustin, Lynn B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FCRL4 PROTEIN; GALECTIN 1; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN M; INTERLEUKIN 4 RECEPTOR; PEGINTERFERON; RHEUMATOID FACTOR; RIBAVIRIN; TRANSCRIPTION FACTOR SOX5; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; LYMPHOCYTE SUBPOPULATION; MALE; MALIGNANT TRANSFORMATION; MARGINAL ZONE LYMPHOMA; MEMORY CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; UPREGULATION;

EID: 79956259577     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-312942     Document Type: Article

References (50)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327(21):1490-1495.
2. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5(4):227-236. (Pubitemid 40410068)
3. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297(18):2010-2017. (Pubitemid 46740353)
4. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89-94. (Pubitemid 34753478)
5. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 2009;76(8):818-824.
6. Charles ED, Green RM, Marukian S, et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood. 2008;111(3):1344-1356. (Pubitemid 351213421)
7. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood. 1998;91(7):2433-2442. (Pubitemid 28155518)
8. Isnardi I, Ng YS, Menard L, et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026-5036.
9. Ek S, Hogerkorp CM, Dictor M, Ehinger M, Borrebaeck CA. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res. 2002;62(15):4398-4405. (Pubitemid 34827299)
10. Gutierrez NC, Ocio EM, de Las Rivas J, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia. 2007;21(3):541-549.
11. Rijkers ES, de Ruiter T, Baridi A, Veninga H, Hoek RM, Meyaard L. The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. Mol Immunol. 2008;45(4):1126-1135. (Pubitemid 350016325)
12. Clark AG, Chen S, Zhang H, et al. Multifunctional regulators of cell growth are differentially expressed in anergic murine B cells. Mol Immunol. 2007;44(6):1274-1285. (Pubitemid 44415966)
13. Tabrizi SJ, Niiro H, Masui M, et al. T cell leukemia/ lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J Immunol. 2009;182(3):1490-1499.
14. Yu X, Siegel R, Roeder RG. Interaction of the B cell-specific transcriptional coactivator OCA-B and galectin-1 and a possible role in regulating BCR-mediated B cell proliferation. J Biol Chem. 2006;281(22):15505- 15516. (Pubitemid 43855143)
15. Cohen O, Feinstein E, Kimchi A. DAP-kinase is a Ca2+/calmodulin- dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 1997;16(5):998-1008. (Pubitemid 27113179)
16. Zhu M, Granillo O, Wen R, et al. Negative regulation of lymphocyte activation by the adaptor protein LAX. J Immunol. 2005;174(9):5612-5619. (Pubitemid 40593202)
17. Ludlow LE, Johnstone RW, Clarke CJ. The HIN- 200 family: more than interferon-inducible genes? Exp Cell Res. 2005;308(1):1-17. (Pubitemid 40984758)
18. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood. 2005;106(5):1831-1838. (Pubitemid 41208601)
19. Briggs RC, Briggs JA, Ozer J, et al. The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cells. Blood. 1994;83(8):2153-2162. (Pubitemid 24112726)
20. Storlazzi CT, Albano F, Lo Cunsolo C, et al. Up-regulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. Leukemia. 2007;21(10):2221-2225. (Pubitemid 47423824)
21. Kost CB, Holden JT, Mann KP. Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis. Cytometry B Clin Cytom. 2008;74(5):282-286.
22. Kanellis G, Roncador G, Arribas A, et al. Identification of MNDA as a new marker for nodal marginal zone lymphoma. Leukemia. 2009;23(10):1847-1857.
23. Sagaert X, de Paepe P, Libbrecht L, et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(16):2490-2497. (Pubitemid 46630625)
24. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350(18):1828-1837. (Pubitemid 38917249)
25. Habermann TM, Wang SS, Maurer MJ, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood. 2008;112(7):2694-2702.
26. Postigo AA, Corbi AL, Sanchez-Madrid F, de Landazuri MO. Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes: relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J Exp Med. 1991;174(6):1313-1322.
27. Tangye SG, van de Weerdt BC, Avery DT, Hodgkin PD. CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2. Eur J Immunol. 2002;32(6):1640-1649. (Pubitemid 34679152)
28. Tomayko MM, Anderson SM, Brayton CE, et al. Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities. J Immunol. 2008;181(1):27-38.
29. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med. 2008;205(8):1807-1817.
30. Carbonari M, Caprini E, Tedesco T, et al. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J Immunol. 2005;174(10):6532-6539. (Pubitemid 40667522)
31. Potter KN, Li Y, Mageed RA, Jefferis R, Capra JD. Molecular characterization of the VH1- specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. Scand J Immunol. 1999;50(1):14-20. (Pubitemid 29298021)
32. Charles ED, Orloff MI, Dustin LB. A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells. J Immunol Methods. 2011;363(2):210-220.
33. Moir S, Ho J, Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205(8):1797-1805.
34. Falini B, Tiacci E, Pucciarini A, et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa- associated lymphoid tissue (MALT). Blood. 2003;102(10):3684-3692. (Pubitemid 37409389)
35. Ehrhardt GR, Hsu JT, Gartland L, et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med. 2005;202(6):783-791. (Pubitemid 41345967)
36. Rothstein TL. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res. 2000;10(4):245-266.
37. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A. 2003;100(23):13489-13494. (Pubitemid 37444769)
38. Segundo C, Medina F, Rodriguez C, Martinez- Palencia R, Leyva-Cobian F, Brieva JA. Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis. Blood. 1999;94(3):1012-1020. (Pubitemid 29361833)
39. Wehr C, Eibel H, Masilamani M, et al. A new CD21low B-cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004;113(2):161-171. (Pubitemid 39296849)
40. Rakhmanov M, Keller B, Gutenberger S, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate- like B cells. Proc Natl Acad Sci U S A. 2009;106(32):13451-13456.
41. Weiss GE, Crompton PD, Li S, et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol. 2009;183(3):2176-2182.
42. Moir S, Malaspina A, Pickeral OK, et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med. 2004;200(7):587-599. (Pubitemid 39258308)
43. Racanelli V, Frassanito MA, Leone P, et al. Antibody production and in vitro behavior of CD27- defined B-cell subsets: persistent hepatitis C virus infection changes the rules. J Virol. 2006;80(8):3923-3934.
44. De Re V, Pavan A, Sansonno S, Sansonno D, Racanelli V. Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients. Ann N Y Acad Sci. 2009;1173:326-333.
45. Cacoub P, Hausfater P, Musset L, Piette JC. Mixed cryoglobulinemia in hepatitis C patients: GERMIVIC. Ann Med Interne (Paris). 2000;151(1):20-29. (Pubitemid 30180104)
46. Monti G, Pioltelli P, Saccardo F, et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med. 2005;165(1):101-105. (Pubitemid 40096090)
47. Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol. 2009;16(3):265-273.
48. Corti D, Suguitan AL Jr, Pinna D, et al. Hetero-subtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest. 2010;120(5):1663-1673.
49. Huang CC, Venturi M, Majeed S, et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor- binding site on gp120. Proc Natl Acad Sci U S A. 2004;101(9):2706-2711. (Pubitemid 38327675)
50. Chan CH, Hadlock KG, Foung SK, Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood. 2001;97(4):1023-1026. (Pubitemid 32154288)